Kimia Biosciences Limited (BSE: 530313)
Health Care · Pharmaceuticals · IN
Rs27.92
-3.52% today · -27.4% 1Y
Kimia Biosciences Limited (BSE: 530313) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $13.81M.
Over the last twelve months the share price has lost 27.4%, trading between 23.20 and 43.28.
Tweenvest scores Kimia Biosciences Limited across four factors: quality 57/100, value 56/100, growth 0/100. Its strongest factor is quality.
530313 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $13.81M
- Revenue (TTM)
- $11.85M
- P/E
- 17.42
- EPS
- 1.60
- Dividend yield
- —
- Beta (5Y)
- 1.19
- 52-week high
- Rs43.28
- 52-week low
- Rs23.20
- Avg volume (3M)
- —
- Shares outstanding
- 47.31M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,194.40 | -3.18% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.26 | -1.05% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.24 | -2.05% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.41 | -0.56% |
Figures last refreshed Aug 18, 2026.